节点文献

缺血性脑卒中二级预防药物治疗依从性研究

Treatment compliance in secondary prevention of ischemic stroke

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 董蒙孟学刚朱沂焦燕祖合热阿依·牙合甫玛依努尔·买买提李红燕

【Author】 DONG Meng;MENG Xue-gang;ZHU Yi;Department of Neurology,People’s Hospital of Xinjiang Uygur Autonomous Region;

【机构】 新疆维吾尔自治区人民医院神经内科

【摘要】 目的 了解缺血性脑卒中患者二级预防药物依从情况,为卒中二级预防工作的实施提供依据。方法 前瞻性地连续纳入乌鲁木齐地区缺血性卒中患者242例,记录患者从住院开始到出院12个月内的服药情况、停药原因。结果 缺血性脑卒中患者出院12个月时抗血栓药物服用率为55.8%(135/242),民族(OR=4.007,95%CI=1.768~9.080)、文化程度(OR=2.953,95%CI=1.493~5.840)、支付方式(OR=0.189,95%CI=0.060~0.594)、血脂异常病史(OR=0.424,95%CI=0.217~0.831)与依从性相关。患者在出院12个月时调脂药物的服用率为59.9%(145/242),文化程度(OR=3.613,95%CI=1.844~7.082)、支付方式(OR=0.254,95%CI=0.091~0.711)、血脂异常病史(OR=0.340,95%CI=0.179~0.648)与依从性相关。合并高血压病患者在出院12个月时降压药的服用率为71.9%(138/192),合并糖尿病患者出院12个月降糖药物的服药率为64.8%(59/91)。抗血栓药物、调脂药物依从性差主要原因为症状改善停药、认为无须服药等。降压药物、降糖药物依从性差原因主要为检查指标好转、认为无须服药等。结论 缺血性脑卒中患者二级预防药物依从性普遍偏低,提醒临床医生应对患者的二级预防用药加强指引作用。

【Abstract】 Objective To investigate the status of medicine compliance in secondary prevention of ischemic stroke,in order to provide evidence for the secondary prevention.Methods Data of 242 continuous ischemic stroke patients in Urumqi were prospectively collected.Information of medicine and reasons of ceasing durgs was registered in 12 months.Results The rate of taking antithrombotic drugs one year after discharged was 55.8%(l35/242).The nationality(OR=4.007,95%CI=1.768-9.080),degree of education(OR=2.953,95%CI=1.493-5.840),pattern of payment(OR=0.189,95%CI=0.060-0.594),dyslipidemia(OR=0.424,95%CI=0.217-0.83l) were associated with treatment compliance one year after discharged.The rate of taking stains one year after discharged was 59.9%(l45/242).The degree of education(OR=3.613,95%CI=1.844-7.082),pattern of payment(OR=0.254,95%CI=0.091-0.711),dyslipidemia(OR=0.340,95%CI=0.179-0.648)were associated with compliance of medicine one year after discharged.The rates of taking hypotensor and hypoglycemic agent one year after discharged were 71.9%(138/192) and 64.8%(59/91).The main reasons of poor compliance of antithrombotic drugs and stains were symptoms improved and ignoring the treatment.The main reasons of poor compliance of hypotensor and hypoglycemic agent were indicators improved and ignoring the treatment.Conclusions The treatment compliance in secondary prevention of ischemic stroke patients is generally poor.The clinicians should focus on the secondary prevention guidance.

【基金】 新疆维吾尔自治区自然科学基金(2015211C188)
  • 【文献出处】 神经疾病与精神卫生 ,Journal of Neuroscience and Mental Health , 编辑部邮箱 ,2017年05期
  • 【分类号】R743.3
节点文献中: 

本文链接的文献网络图示:

本文的引文网络